Sports MedicineKneeSurgery Center

ACL Reconstruction — Allograft

Christopher Raffo, MD, John Christoforetti, MD, and James Gardiner, MD are fellowship-trained orthopedic surgeons who use allograft selectively — matching it to the patients for whom it is genuinely the right choice, and being direct with younger patients about its limitations.

Duration: 45–75 minutesAnesthesia: General or spinal

Schedule a Consultation

What is acl reconstruction — allograft?

ACL allograft reconstruction replaces the torn ACL using sterilized cadaveric tendon tissue — most commonly patellar, Achilles, or anterior tibialis tendon from a tissue bank. It eliminates donor-site morbidity and shortens operative time, making it appropriate for older, lower-demand patients and complex multi-ligament reconstructions. It is not recommended as a primary graft for young athletes or competitive players under 40 due to significantly higher re-rupture rates documented in multiple studies.

Why this approach — at MOS

We use allograft tissue in ACL reconstruction for a defined, appropriate patient population, and we are direct with patients about its limitations for younger athletes. Transparency is central to how we counsel patients at MOS, particularly on a topic where patient expectations and the published evidence can diverge significantly.

For a 50-year-old recreational skier who wants to return to blue runs and intermediate terrain — not moguls or competition — allograft is a genuinely good option. Eliminating the harvest incision, shortening the procedure, and avoiding the recovery complications of autograft harvest are meaningful advantages when the elevated re-rupture risk in young athletes is not the relevant clinical concern.

For a 19-year-old soccer player, we present the data directly. The failure rate difference between autograft and allograft in that population is not subtle. We believe patients — and their parents, when minors — deserve to understand this clearly. A patient who chooses allograft after a full, informed discussion has made a legitimate choice. A patient who chooses allograft without understanding the failure-rate data has not truly consented.

Our practice at Rockville, Bethesda, and Germantown serves patients across a wide age and activity spectrum. We match our graft recommendations to where each patient sits on that spectrum.

Who is a candidate?

Appropriate Indications for Allograft

Patients over 40 with a complete ACL tear who have moderate activity demands — recreational hiking, skiing, doubles tennis — and prefer to avoid a harvest incision
Sedentary or low-demand patients of any age for whom eliminating donor-site morbidity and shortening anesthesia time is a meaningful benefit
Multi-ligament knee reconstruction (combined ACL + PCL, or ACL + collateral ligament injuries) where multiple graft sources are needed and autograft supply is insufficient
Patients undergoing revision ACL reconstruction where all autograft sources have been previously harvested
Older patients who are highly motivated to return to recreational activity but for whom the rotational stress of high-level sport is not a goal

When Allograft Is NOT Recommended

Competitive athletes under 40 in pivoting or cutting sports — the re-rupture rate data is clear and patients deserve to hear it directly
Patients under 25 at any activity level — the age-related failure rate increase is well-documented
Young patients returning to military service, law enforcement, or other physically demanding occupational demands
Athletes who have already experienced one ACL failure and are considering revision — autograft is strongly preferred for revision surgery

Conservative Treatment First

Not every ACL tear requires reconstruction, regardless of graft type. For older, less active patients presenting with an ACL tear, a careful trial of physical therapy, bracing, and activity modification is always appropriate before committing to surgery. Many patients over 50 with low activity demands and an ACL tear function well without reconstruction if their daily activities do not involve pivoting. At Maryland Orthopedic Specialists, we begin with a full assessment of functional demands and only recommend reconstruction — with any graft — when surgery will meaningfully improve the patient's quality of life and functional capacity.

The procedure

What Is ACL Reconstruction with an Allograft?

Allograft tissue is processed and sterilized by accredited tissue banks under strict FDA-regulated standards. Common processing methods include low-dose gamma irradiation, chemical treatment, or aseptic (clean-room) processing without irradiation. The method of sterilization matters: irradiation — particularly at higher doses — has been shown to alter the mechanical properties of the graft tissue, reducing its strength and potentially contributing to higher failure rates. Non-irradiated, aseptically processed allografts generally maintain better mechanical properties than irradiated ones.

The most commonly used allograft sources for ACL reconstruction are:

Bone-patellar tendon-bone allograft — mirrors the anatomy of the BPTB autograft
Achilles tendon allograft — large cross-sectional area; includes a calcaneal bone plug at one end
Anterior tibialis tendon allograft — soft tissue only; used frequently in multi-ligament reconstruction

There is no tissue matching (like blood typing in organ transplant) required for allograft tendons. Immune rejection in the traditional transplant sense does not occur, although some degree of immune response to the foreign tissue does take place and may slow the ligamentization process.

What Happens During Allograft ACL Reconstruction?

The surgical technique for allograft ACL reconstruction is similar to autograft reconstruction, with one key difference: there is no harvest step.

Step 1 — Graft preparation. The processed allograft is received from the tissue bank, thawed according to protocol, and prepared on the back table. Sutures are placed, the graft is sized, and any bone plugs are shaped to fit the tunnel.

Step 2 — Arthroscopic inspection. Arthroscopic portals allow full knee inspection. Meniscal or cartilage pathology is addressed. The torn ACL remnants are debrided.

Step 3 — Tunnel drilling. Bone tunnels are drilled at the anatomic ACL footprint in the tibia and femur using the same technique as autograft reconstruction. Anatomic tunnel placement is equally important with allograft.

Step 4 — Graft passage and fixation. The allograft is passed and fixed in the tunnels using interference screws, cortical buttons, or a combination. Fixation technique is similar to autograft. In Achilles allograft, the bone plug occupies the femoral tunnel; the soft-tissue end is fixed at the tibia.

Step 5 — Closure. Without a harvest incision, the only incisions are the two or three small arthroscopic portals. The procedure typically takes 45–75 minutes — shorter than autograft reconstruction by 15–30 minutes. Patients are discharged home the same day.

Recovery timeline

Days 1–14 (Early Phase)

Crutches and hinged brace. Without a harvest incision, some patients experience less early postoperative pain than with autograft — though the intra-articular portion of the procedure is identical and intra-articular swelling and pain are still present. Ice, elevation, early range of motion.

Weeks 2–6 (Motion Phase)

Progressive weight-bearing and motion. No harvest-site pain. The knee responds similarly to autograft in this phase.

Weeks 6–12 (Strengthening)

Closed-chain strengthening begins. Protocol mirrors autograft in the strengthening phase.

Months 3–6 (Functional Phase)

Running at 3–4 months if strength benchmarks are met. An important caveat: allograft tissue undergoes ligamentization more slowly than autograft. The biologic process of converting the implanted tendon into functional ligament tissue is delayed with allograft — some studies suggest ligamentization may take 2–3 years vs. 12–18 months for autograft. The clinical implication is caution about aggressive early return to pivoting activity.

Months 6–9 (Sport-Specific)

Progressive sport-specific training for appropriate patients.

9–12+ Months (Return to Activity)

Return-to-sport criteria are applied the same way as autograft, but given slower ligamentization, some surgeons prefer a 12-month minimum before full return to pivoting sports.

The absence of a donor-site incision is the primary recovery advantage of allograft. Patients do not experience harvest-site pain, patellar tendon soreness, or hamstring-quadriceps strength ratio concerns. Early rehabilitation is often perceived as smoother than autograft. This relative ease of early recovery may, counterintuitively, contribute to premature return to high-demand activity — which is one proposed explanation for higher failure rates in younger patients who push return-to-sport faster than their graft can support.

Physical therapy protocols at MOS for allograft ACL reconstruction are intentionally conservative in the return-to-sport timeline, reflecting the slower ligamentization biology. The absence of harvest-site pain should not be interpreted as a license to return to sport earlier.

Frequently Asked Questions

Is allograft safe? Could I get a disease from cadaveric tissue?

The risk of disease transmission from properly processed allograft tissue is extremely low. All tissue banks used by accredited hospitals and surgical centers are FDA-regulated and follow the American Association of Tissue Banks (AATB) standards, which include donor screening, serologic testing, and sterilization protocols. The estimated risk of HIV transmission from allograft is less than 1 in 1 million — far lower than many other medical risks patients routinely accept. The more clinically relevant concern is not safety but rather the higher failure rate in young, active patients.

Why is allograft appropriate for older patients but not younger ones?

The failure-rate gap between autograft and allograft narrows significantly with age and decreasing activity demand. In young, high-demand athletes, the allograft failure rate approaches 25% vs. approximately 10% for autograft — a meaningful difference when the patient is 19 and returning to collegiate soccer. In a 55-year-old recreational hiker, the absolute failure risk for both graft types is lower, and the difference between them is smaller. The absence of a donor site and shorter procedure become more relevant advantages when the overall failure risk is low.

Can I use allograft if I am over 40 and still active in recreational sports?

Yes — this is often the ideal use case for allograft. A 42-year-old recreational tennis player, skier, or cyclist with an ACL tear who does not intend to return to competitive pivoting sport is an appropriate allograft candidate. The re-rupture risk data showing large failure-rate increases with allograft applies most strongly to competitive athletes under 25. By age 40+, with recreational demands, the tradeoffs shift in allograft's favor.

Will my body reject the allograft?

Not in the classic transplant rejection sense — the tendons do not carry the same immunogenicity as solid organs. There is no need for immunosuppressive drugs. However, allograft tissue does elicit some immune response, which contributes to the slower ligamentization timeline compared to autograft. This immune response is well-tolerated by most patients and does not cause clinical rejection.

Is there a longer recovery with allograft?

The recovery timeline is similar to autograft in terms of milestones, but allograft tissue undergoes biological incorporation (ligamentization) more slowly. Most surgeons recommend a 12-month minimum before return to full pivoting-sport competition with allograft, compared to 9–12 months for autograft. The early recovery (first 3 months) is sometimes perceived as smoother because there is no harvest-site pain.

My surgeon recommended allograft. Should I be concerned?

Context matters. If your surgeon recommends allograft because you are over 40, have lower activity demands, or because you are undergoing a multi-ligament reconstruction where multiple graft sources are needed — that is a well-supported clinical recommendation. If you are under 30, competitive, and no specific reason for allograft has been discussed, it is entirely appropriate to ask your surgeon to walk through the failure-rate data and the reasoning for their recommendation. Informed decision-making requires understanding the tradeoffs.

What types of allograft tendon are used for ACL reconstruction?

The most common choices are: bone-patellar tendon-bone allograft (mirrors the BPTB autograft anatomy), Achilles tendon allograft (large cross-section, includes calcaneal bone plug), and anterior tibialis tendon allograft (soft tissue only, often used in multi-ligament cases). The choice between these depends on surgeon preference, graft availability, and whether bone plug fixation is desired at one or both ends.

Related conditions

ACL Tear Meniscus Tear

Related procedures

Meniscus Repair Lateral Extra-Articular Tenodesis (LET)

Medically reviewed by Christopher S. Raffo, MD

Last reviewed May 20, 2026